Zacks Investment ResearchThu, 02 Jul 2026 15:01:15 GMTRevvity Expands Signals AI With Anthropic Claude IntegrationRVTY+3.29%
Zacks Investment ResearchTue, 23 Jun 2026 13:50:33 GMTRevvity Launches Signals AI to Advance Scientific R&D WorkflowsRVTY+3.29%
Seeking AlphaTue, 09 Jun 2026 14:52:14 GMTRevvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptRVTY+3.29%
Zacks Investment ResearchThu, 04 Jun 2026 16:35:53 GMTWhy Is Revvity (RVTY) Up 2% Since Last Earnings Report?RVTY+3.29%
Zacks Investment ResearchThu, 14 May 2026 17:01:11 GMTRVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone AssayRVTY+3.29%
Seeking AlphaWed, 13 May 2026 19:10:48 GMTRevvity, Inc. (RVTY) Presents at Bank of America Global Healthcare Conference 2026 TranscriptRVTY+3.29%
Zacks Investment ResearchTue, 05 May 2026 15:41:07 GMTRVTY Q1 Earnings Beat Estimates on Organic Growth & Strong ExecutionRVTY+3.29%
Seeking AlphaTue, 05 May 2026 15:01:13 GMTRevvity, Inc. (RVTY) Q1 2026 Earnings Call TranscriptRVTY+3.29%
Zacks Investment ResearchTue, 05 May 2026 14:30:40 GMTCompared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key MetricsRVTY+3.29%
Zacks Investment ResearchTue, 05 May 2026 12:45:27 GMTRevvity (RVTY) Q1 Earnings and Revenues Top EstimatesRVTY+3.29%
Zacks Investment ResearchMon, 04 May 2026 13:50:59 GMTRevvity to Report Q1 Earnings: What's in Store for the Stock?RVTY+3.29%
Zacks Investment ResearchMon, 13 Apr 2026 16:00:22 GMTRVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D DataRVTY+3.29%
